-
1
-
-
34548473335
-
Signal detection methodologies to support effective safety management
-
van Manen RP, Fram D, DuMochel W. Signal detection methodologies to support effective safety management. Expert Opin Drug Saf 2007; 6: 451-64.
-
(2007)
Expert Opin Drug Saf
, vol.6
, pp. 451-464
-
-
van Manen, R.P.1
Fram, D.2
DuMochel, W.3
-
2
-
-
58149275933
-
-
Forskrift om legemidler. Kap. 11. www.lovdata.no/for/sf/ho/xo-19991222- 1559.html (24.8. 2007).
-
Forskrift om legemidler. Kap. 11. www.lovdata.no/for/sf/ho/xo-19991222- 1559.html (24.8. 2007).
-
-
-
-
4
-
-
58149276049
-
-
12.11
-
Lov om apotek. Kap. 6. www.lovdata.no/all/hl-20000602-039.html (12.11.2008).
-
(2008)
Lov om apotek. Kap. 6
-
-
-
6
-
-
58149257504
-
-
Committee for proprietary medicinal products (CPMP), The European agency for the evaluation of medicinal products (EMEA). Note for guidance on the investigation of bioavailability and bioequivalence. www.emea.europa.eu/pdfs/ human/ewp/140198en.pdf (17.8.2007).
-
Committee for proprietary medicinal products (CPMP), The European agency for the evaluation of medicinal products (EMEA). Note for guidance on the investigation of bioavailability and bioequivalence. www.emea.europa.eu/pdfs/ human/ewp/140198en.pdf (17.8.2007).
-
-
-
-
7
-
-
58149225426
-
-
12.11
-
Statens legemiddelverk. Overvåkingsliste. www.legemiddelverket.no/ upload/2008-09-15%20Legemidler%20under%20særlig%20overvåking.pdf (12.11.2008).
-
(2008)
Statens legemiddelverk. Overvåkingsliste
-
-
-
8
-
-
0346929455
-
Generisk substitusjon - bitter pille for legene
-
Halvorsen P. Generisk substitusjon - bitter pille for legene. Tidsskr Nor Lægeforen 2000; 120: 1082-3.
-
(2000)
Tidsskr Nor Lægeforen
, vol.120
, pp. 1082-1083
-
-
Halvorsen, P.1
-
9
-
-
58149276048
-
Pass opp for generisk substitusjon!
-
Johannessen LB. Pass opp for generisk substitusjon! Tidsskr Nor Lægeforen 2001; 121: 1756.
-
(2001)
Tidsskr Nor Lægeforen
, vol.121
, pp. 1756
-
-
Johannessen, L.B.1
-
12
-
-
0025330184
-
Quality criteria for early signals of possible adverse drug reactions
-
Edwards R, Lindquist M, Wiholm B-E et al. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990; 336: 156-8.
-
(1990)
Lancet
, vol.336
, pp. 156-158
-
-
Edwards, R.1
Lindquist, M.2
Wiholm, B.-E.3
-
13
-
-
58149257503
-
-
Uppsala Monitoring Centre. The WHO adverse drug reactions database on-line searches user's manual. 1997. www.who.int/medicines/areas/ quality_safety/safety_efficacy/advdrugreactions/ en/ (28.8.2008).
-
Uppsala Monitoring Centre. The WHO adverse drug reactions database on-line searches user's manual. 1997. www.who.int/medicines/areas/ quality_safety/safety_efficacy/advdrugreactions/ en/ (28.8.2008).
-
-
-
-
14
-
-
58149221546
-
-
Lindquist M. Seeing and observing in international pharmacovigilance - achievements and prospects in worldwide drug safety. Doktoravhandling. Nijmegen: University of Nijmegen, 2003.
-
Lindquist M. Seeing and observing in international pharmacovigilance - achievements and prospects in worldwide drug safety. Doktoravhandling. Nijmegen: University of Nijmegen, 2003.
-
-
-
-
15
-
-
34548729790
-
Characteristics and quality of adverse drug reaction reports by pharmacists in Norway
-
Gedde-Dahl A, Harg P, Stenberg-Nilsen H et al. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Saf 2007; 16: 999-1005.
-
(2007)
Pharmacoepidemiol Drug Saf
, vol.16
, pp. 999-1005
-
-
Gedde-Dahl, A.1
Harg, P.2
Stenberg-Nilsen, H.3
-
23
-
-
33644897344
-
Generic substitution: The use of medicinal products containing different salts and implications for safety and efficacy
-
Verbeck RK, Kanfer I, Walker RB. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy. Eur J Pharm Sci 2006; 28: 1-6.
-
(2006)
Eur J Pharm Sci
, vol.28
, pp. 1-6
-
-
Verbeck, R.K.1
Kanfer, I.2
Walker, R.B.3
-
24
-
-
58149222868
-
-
10.2
-
Food and drug administration, FDA. Amlodipine citizen petition. www.fda.gov/ohrms/dockets/ dailys/03/Sept03/090303/03p-0408-cp00001-08-Tab-G- vol3.pdf (10.2.2007).
-
(2007)
Amlodipine citizen petition
-
-
-
26
-
-
58149222865
-
-
European medicines agency (EMEA). Notice to applicants. Nr. 3B. Guidelines for medicinal products for human use. Safety, environment and information. Excipients in the label and package leaflet of medicinal products for human use. www.emea.europa.eu/pdfs/human/productinfo/3bc7a_200307en.pdf (6.4.2008).
-
European medicines agency (EMEA). Notice to applicants. Nr. 3B. Guidelines for medicinal products for human use. Safety, environment and information. Excipients in the label and package leaflet of medicinal products for human use. www.emea.europa.eu/pdfs/human/productinfo/3bc7a_200307en.pdf (6.4.2008).
-
-
-
|